Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pmv Pharmaceuticals Inc (PMVP)

Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pmv Pharmaceuticals Inc 400 Alexander Park Drive Suite 301 Princeton NJ 08540 USA

www.pmvpharma.com Employees: 47 P: 609-642-6670

Sector:

Medical

Description:

PMV Pharmaceuticals Inc.is a precision oncology company. It engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. PMV Pharmaceuticals Inc.is headquartered in Cranbury, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 65,983
Enterprise Value, $K 25,103
Shares Outstanding, K 53,212
Annual Sales, $ 0 K
Annual Net Income, $ -58,710 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,060 K
EBIT, $ -92,130 K
EBITDA, $ -96,360 K
60-Month Beta 1.64
% of Insider Shareholders 7.57%
% of Institutional Shareholders 90.20%
Float, K 49,184
% Float 92.43%
Short Interest 1,574
Short Float 2.96%
Short Volume Ratio 0.10

Growth:

1-Year Return -18.67%
3-Year Return -85.75%
5-Year Return -97.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 11/12/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -1.60
EPS Growth vs. Prev Qtr 2.44%
EPS Growth vs. Prev Year -8.11%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PMVP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.34%
Return-on-Assets % -51.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 2.28
Interest Coverage -1.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar